SEAGEN INC's ticker is SGEN and the CUSIP is 81181C104. A total of 598 filers reported holding SEAGEN INC in Q2 2023. The put-call ratio across all filers is 1.73 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $615,235 | +10.2% | 2,900 | 0.0% | 0.04% | +14.7% |
| Q2 2023 | $558,134 | -4.9% | 2,900 | 0.0% | 0.03% | -10.5% |
| Q1 2023 | $587,163 | +57.6% | 2,900 | 0.0% | 0.04% | +52.0% |
| Q4 2022 | $372,679 | -6.1% | 2,900 | 0.0% | 0.02% | -13.8% |
| Q3 2022 | $397,000 | -22.6% | 2,900 | 0.0% | 0.03% | -19.4% |
| Q2 2022 | $513,000 | +22.7% | 2,900 | 0.0% | 0.04% | +50.0% |
| Q1 2022 | $418,000 | +42.2% | 2,900 | +52.6% | 0.02% | +33.3% |
| Q4 2021 | $294,000 | -9.0% | 1,900 | 0.0% | 0.02% | -18.2% |
| Q3 2021 | $323,000 | +7.7% | 1,900 | 0.0% | 0.02% | +10.0% |
| Q2 2021 | $300,000 | +13.6% | 1,900 | 0.0% | 0.02% | 0.0% |
| Q1 2021 | $264,000 | -53.0% | 1,900 | -40.8% | 0.02% | -57.4% |
| Q4 2020 | $562,000 | – | 3,209 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 47,288,259 | $7,465,870,000 | 32.79% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 145,000 | $22,868,000 | 6.04% |
| Lagoda Investment Management, L.P. | 59,780 | $9,438,000 | 4.40% |
| Avidity Partners Management LP | 640,000 | $101,043,000 | 2.73% |
| PFM Health Sciences, LP | 482,985 | $76,254,000 | 2.39% |
| Boxer Capital, LLC | 400,000 | $63,152,000 | 2.23% |
| Redmile Group, LLC | 771,385 | $121,786,000 | 1.80% |
| Woodline Partners LP | 577,655 | $91,200,000 | 1.70% |
| Rhenman & Partners Asset Management AB | 157,925 | $24,933,000 | 1.69% |
| Parkman Healthcare Partners LLC | 45,176 | $7,132,000 | 1.56% |